In Vitro Maturation of Immature Oocytes

This study has been completed.

Sponsor:

Information provided by:

Sheba Medical Center

ClinicalTrials.gov Identifier:

NCT00480337

First received: May 29, 2007

Last updated: December 16, 2008

Last verified: December 2008

History of Changes

Tracking Information

First Received Date ^ICMJE

May 29, 2007

Last Updated Date

December 16, 2008

Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00480337 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

In Vitro Maturation of Immature Oocytes

Official Title ^ICMJE

Not Provided

Brief Summary

The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Condition ^ICMJE

Polycystic Ovary Syndrome
Ovarian Hyperstimulation Syndrome

Intervention ^ICMJE

Procedure: In Vitro Maturation of immature oocytes

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Women with PCOS
Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
Women diagnosed with cancer who are interested in fertility preservation
Women with repeated IVF failure

Exclusion Criteria:

Severe cases of endometriosis
Large myomas
Hydrosalpinxs Technical problem with previous oocytes pick-up

Gender

Female

Ages

20 Years to 45 Years

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Israel

Administrative Information

NCT Number ^ICMJE

NCT00480337

Other Study ID Numbers ^ICMJE

SHEBA-06-4317-AH-CTIL

Has Data Monitoring Committee

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Sheba Medical Center

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Ariel Hourvitz

IVF Unit, Sheba Medical Center

Information Provided By

Sheba Medical Center

Verification Date

December 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top